✦ LIBER ✦

Surrogate endpoints in randomized cardiovascular clinical trials

✍ Scribed by Michael Domanski; Stuart Pocock; Corine Bernaud; Jeffrey Borer; Nancy Geller; James Revkin; Faiez Zannad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate endpoint use in cardiovascular

✍ J.L. Probstfield; S. Yusuf; L.M. Friedman; D.R. Labarthe; J.D. Bristow; J. Witte 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Surrogate endpoints in clinical trials

✍ Lawrence Friedman; Salim Yusuf 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Clinical trials: surrogate endpoints or

✍ Lewis H Kuller 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 51 KB

02 The validation of surrogate endpoints

✍ Gert Molenberghs; Marc Buyse 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Biomarkers and surrogate endpoints in cl

✍ Thomas R. Fleming; John H. Powers 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

Validation of Surrogate Endpoints in Mul

✍ Didier Renard; Helena Geys; Geert Molenberghs; Tomasz Burzykowski; Marc Buyse 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views